TERRY WHITE CHEMISTS RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

risedronate sodium, Quantity: 35 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Risedronate sodium

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: lactose; macrogol 8000; colloidal anhydrous silica; titanium dioxide; magnesium stearate; hypromellose; iron oxide red; iron oxide yellow; crospovidone; hyprolose

Mode d'administration:

Oral

Unités en paquet:

Pack sizes of 7, 14, 28, 84, 112 tablets per pack

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Treatment of osteoporosis.,Treatment of glucocorticoid-induced osteoporosis. ,Preservation of bone mineral density in patients on long term corticosteroid therapy

Descriptif du produit:

Visual Identification: Risedronate tablets are orange round biconvex coated tablets engraved APO on one side RIS above 35 on the other side; Container Type: Multiple containers; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-04-13